Trial reportPloS one2026
An intervention study of the general practice management of older adults with cardiovascular metabolic comorbidities.
Trial report in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo investigate the impact of general practice management on treatment compliance, lifestyle, and clinical indicators in older adults with cardiovascular metabolic comorbidities to provide more effective disease management strategies for this population. PATIENTS AND
methodsThis randomized controlled trial enrolled 200 older adults with type 2 diabetes and established atherosclerotic cardiovascular disease (e.g., coronary heart disease, ischemic stroke) who were discharged from Qinhuangdao First Hospital between November 2021 and May 2023. Patients were randomly divided into intervention and control groups (n = 100 per group). The intervention group received general medical management, including personalized health education during hospitalization, community outpatient follow-up after discharge, and lifestyle interventions. The control group received routine discharge guidance. Changes in medication usage, body mass index (BMI), smoking rate, and clinical indicators, such as glycated hemoglobin, low-density lipoprotein cholesterol, and creatinine levels were evaluated over a 12-month follow-up period. Dietary intake and physical activity were assessed using the Semi-Quantitative Food Frequency Survey Questionnaire and the Physical Activity Scale for the Elderly, respectively.
resultsAfter 12 months, 91 controls and 95 intervention patients remained and were analyzed per-protocol. Within-group analyses revealed that the intervention group successfully maintained high utilization rates of all recommended medications (metformin, SGLT2i, GLP-1RA, aspirin/clopidogrel, statins, ACEI/ARB), whereas the control group experienced significant declines (all P < 0.05). Both groups achieved significant reductions in BMI, but only the intervention group showed a significant decrease in smoking rates (P = 0.014). The intervention group demonstrated comprehensive dietary improvements (e.g., increased nuts, dairy, vegetables, and aquatic products; reduced refined carbohydrates, meats, and salt) and significantly increased physical activity scores (all P < 0.05). Clinically, while both groups achieved reductions in glycated hemoglobin and LDL-C, only the intervention group showed significant improvements in creatinine levels, whereas renal function in the control group significantly deteriorated (P < 0.001).
conclusionA structured general practice management model effectively sustains long-term medication adherence, promotes comprehensive healthy lifestyle modifications, and optimizes key metabolic and renal clinical indicators in older adults with cardiovascular metabolic comorbidities.
trial registrationChinese Clinical Trial Registry ChiCTR2500112212.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.